Alcohol-use disorders (AUDs) represent a large public health burden with relatively few efficacious pharmacotherapies. Randomized controlled trials (RCTs) for new AUD therapies can be hampered by ineffective recruitment, leading to increased trial costs. The current analyses examined the effectiveness of recruitment efforts during 2 consecutive outpatient RCTs of novel AUD pharmacotherapies conducted between 2009 and 2012.
A lcohol-use disorders (AUDs) are highly prevalent in the United States and worldwide. The World Health Organization estimates that 76 million persons meet diagnostic criteria for AUDs and 2.5 million individuals die yearly from alcohol-related causes. 1 Given the global burden of disease and heterogenous causes of AUDs across individuals, it is imperative that optimal and individualized treatments are available to meet the needs of patients in a wide variety of settings. Although 4 accepted medications are available for the treatment of AUDs in the United States and Europe (disulfiram, oral naltrexone, extended-release naltrexone, and acamprosate), 2 these medications do not work for the majority of patients in clinical practice and new pharmacotherapies are needed.
Randomized controlled trials (RCTs) are the gold standard in proving efficacy and obtaining regulatory approval for the use of novel therapies in the treatment of disorders. However, RCTs are expensive and can be hampered by slow recruitment. In fact, poor participant recruitment is one of the most common barriers faced in addiction treatment clinical trials. 3 Although ease of recruitment can be optimized in the design phase (eg, use of less restrictive inclusion/exclusion criteria, limited matching strategies), safety and other protocol-specific concerns may limit the use of these methods.
Recruitment methods in trials of AUD pharmacotherapies have received relatively little attention in the scientific literature even as there is a strong financial commitment from governmental agencies like the National Institute on Alcohol Abuse and Alcoholism (NIAAA) and industry to fund these trials. 4 One study examined telephone calls for an AUD clinical trial participation and found that people referred by friends/ family, yellow pages, or newspaper ads had the highest likelihood of meeting criteria for an in-person screen (IPS) as compared with television (TV), radio, and the internet. 5 However, that study did not examine recruitment effectiveness beyond the phone screen qualification, nor did it examine cost-effectiveness. In addition, that study examined persons with a wide variety of substance-use disorders and did not focus exclusively on AUDs. A secondary analysis of an Australian pharmacotherapy RCT found that there were no significant differences in treatment retention or drinking outcomes between 4 recruitment strategies-inpatient referral, outpatient referral, live media (ie, TV and radio), or print media. 6 The 2 largest AUD trials in the United States, MATCH (Matching Alcoholism Treatments to Client Heterogeneity) and COMBINE (Combining Medications and Behavioral Interventions), have only published descriptions of recruitment methods without any objective data on their efficacy or cost-effectiveness, which would help guide future trial planning. 7, 8 Therefore, the purpose of this analysis was to examine the effectiveness of 8 different advertising methods in attracting eligible participants in 2 consecutive NIAAA funded Phase II clinical trials for the treatment of very heavy drinking. Effectiveness was examined in terms of (1) attraction of analyzable study participants (persons who met study entry criteria, were randomized, and completed the trials) and (2) costs associated with the advertising methods.
MATERIAL AND METHODS
The parent clinical trials were conducted in accordance with Good Clinical Practices (International Conference on Harmonisation, 1996) and were registered on clinicaltrials.gov (NCT00970814 and NCT01146613). Written informed consent was obtained from all participants before engaging in study-related activities. Eligibility criteria and a complete description of the clinical trials are described in detail elsewhere. 9,10 Both trials had similar inclusion/exclusion criteria and lasted for 16 weeks. Separate IRB approval waiving the right to written informed consent was obtained to collect and analyze the present phone screen and enrollment data.
Participants
Both clinical trials were multisite projects. Data presented here are from 1 site in Baltimore, MD-the Behavioral Pharmacology Research Unit (BPRU). As recruitment effectiveness was not a primary outcome for the parent trials, data regarding advertising cost-effectiveness from the other sites were unavailable for analysis. All participants were recruited between September 2009 and January 2012 from the greater Baltimore-Washington, DC metropolitan area. Interested persons called the BPRU, which had 1 phone line exclusively designated for these studies. Research assistants then completed a brief set of standardized questions that asked about drinking habits and willingness to participate in a 16-week outpatient clinical trial. During this screen, callers were asked how they heard about the study (ad source). If calls were not answered immediately, an attempt was made to return all calls within 48 hours. Persons who met eligibility criteria on the phone screen were scheduled for an in-person screening visit. There was a 14-day observation period before randomization in each RCT during which a person had to self-report at least 1 heavy-drinking day (5 or more drinks/drinking day for men or 4 or more drinks/drinking day for women) during the levetiracetam ER RCT and at least 2 heavy-drinking days in the subsequent varenicline RCT. Completers in this analysis were defined as completing all 16 weeks of study visits after randomization.
Recruitment Plan
BPRU's recruitment plan for both studies was developed in consultation with an outside advertising agency familiar with the local media market. Advertisements were designed to target heavy drinkers at places and times that they were likely to consider getting help for their drinking, for example, late night TV ads for people who have consumed too much alcohol, early morning radio and TV ads for people with a hangover getting ready for work, or billboards on heavily trafficked roads. Baltimore, MD is a relatively small city with a population of 620,000, but the 2008 Baltimore-Washington, DC metropolitan area had a population of 8.2 million. 11 This metropolitan area has urban, suburban, and rural subparts, and the advertising strategy recruited from all 3 subparts in these clinical trials.
Recruitment sources included (1) TV ads on network affiliates, (2) print ads in local specialized free publications, subscription magazines catering to suburban audiences, and the daily periodical in Baltimore, (3) bus ads in Baltimore, (4) a billboard (located adjacent to the main highway leading into the downtown Baltimore area), (5) flyers posted by a team of BPRU research assistants around Baltimore, (6) internet (http://www.getcontrol.org, Google AdWords, http://www.clinicaltrials.gov, and Baltimore area business e-mail list serve), (7) radio, and (8) word-ofmouth. Participants did not receive a financial benefit for word-of-mouth referrals. Recruitment was monitored in weekly meetings attended by the PI, study coordinator, research assistants, postdoctoral fellow, and student interns. Changes in advertising strategy were made on a monthly basis. Billboard and radio ads were not purchased for the varenicline RCT on the basis of review of recruitment data after the levetiracetam ER RCT.
Advertisement Costs
Ads were placed both by BPRU's centralized recruitment team (majority of print ads, internet, and flyers) and by the outside ad agency (radio, billboard, bus, some print ads, and TV). Costs reported here included charges for production and running of ads as well as fees charged by the ad agency for placement, and were maintained at the site as part of the ongoing budgetary monitoring process. NIAAA produced and distributed a TV commercial and professional website (http://www.getcontrol.org) exclusively to be used in these clinical trials; these production costs were paid by NIAAA and not the site. There were minimal costs associ-ated with individualizing the TV commercial for the Johns Hopkins site (eg, adding the Hopkins name, logo, and contact information), which were included in the present analyses.
Data Analysis
If >1 advertising modality was reported by a participant, the first source reported by the applicant was used. Differences in demographics across advertising sources were analyzed with Fisher exact and w 2 tests for categorical variables and 1-way analysis of variance for continuous variables. Recruitment effectiveness was determined by dividing the number of persons meeting criteria for an IPS by the total number of callers from each ad source. A w 2 test then looked at differences in recruitment effectiveness among the ad sources. Cost-effectiveness was examined by dividing the total cost of the advertising method by the number of screens, persons randomized, and completers.
RESULTS

Participants Screened
There were a total of 1813 calls during the course of active recruitment, of which 1005 (55%) resulted in a completed phone screen ( Fig. 1 ). Of the 1005, 274 (27%) met screening criteria and were scheduled for an IPS. Sixty-eight percent (187/274) of these persons attended the scheduled screen. Thirty-six percent of IPSs met inclusion/ exclusion criteria and were randomized, with a 78% retention rate for those randomized (completed all 16 wk of the trial).
Demographics
Phone Screens
The only demographic variable collected during phone screens was age (to make an initial determination of eligibility). Relative to the average age of persons assessed during a phone screen (46.3 ± 11.1 y, mean ± SD), participants reporting TV (50. 6 persons recruited from the internet (38 ± 13), word-of-mouth (41.1 ± 12), or who did not identify an ad source (42.6 ± 12.9) were slightly younger. These age differences between ad sources were significantly different on analysis of variance (F = 15.82, df = 8, P = 0.002).
IPS and Randomizations
Persons who participated in an IPS provided information on their sex, race, years of education, marital status, and annual household income. Of those persons attending an IPS, there was no significant difference between ad sources as a function of sex (P = 0.072) ( Table 1 ). However, there were significant differences between ad sources for age (P<0.001), race (P<0.001), years of education (P<0.001), marital status (P<0.001), and annual household income (P<0.001) ( Table 1 ). Of the 187 participants who completed an IPS, 67 were randomized into an RCT. The significant demographic differences between ad sources for these 67 participants were race (P<0.001), marital status (P<0.001), and income (P<0.001).
Recruitment Effectiveness by Ad Source
The most frequently mentioned ad source for all callers was TV (34%), followed by print (29%), word-of-mouth (11%), flyer (8%), internet (5%), radio (5%), bus ad (2%), and billboard (1%) ( Fig. 2A ). Only 51 participants (5%) failed to provide a source of hearing about the study. There was a significant difference between ad sources in the percentage of total callers from each source qualifying and being scheduled for an IPS [w 2 (8, N = 1005) = 23.9, P = 0.002]. Participants reporting print Recruitment Techniques for AUD RCTs www.addictiondisorders.com ads as their ad source had the most number of persons who qualified and were scheduled for an IPS (N = 100; 34% of total), followed by TV (N = 87; 25% of total), and word-of-mouth (N = 28; 26% of total) (Fig. 2B) . Although representing only 3% of all phone screens, those participants reporting bus ads and the billboard as their ad sources were most likely to qualify for an IPS (46% and 44% of participants, respectively). Flyers and word-of-mouth accounted for 18% of all phone screens. Only a small minority of persons reporting flyers qualified for an IPS (17%), whereas word-of-mouth was more successful at recruiting these persons (26%). Of those who qualified for an IPS, there were no significant differences on the Fisher exact test between ad sources on percentage of persons randomized (P = 0.583) or on percentage of persons who completed the study (P = 0.32).
Cost-effectiveness of Ad Sources
There was a total of $175,000 spent on advertising for the BPRU site over the course of the 2 RCTs. Of all the ad sources, the most money was spent on TV ads (approximately $75,000). Although TV ads resulted in the highest number of interested callers for the study at a relatively inexpensive cost ($216 per phone screen), the majority of callers did not qualify for the study, and the costs per IPS ($1245), person randomized ($3113), and study completer ($4151) were much higher than print ads (but less than most other modalities) ( Fig. 3) . Of all ad sources that cost money, print ads led to the second most number of calls and were the most cost-effective ($128 per phone screen, $606 per IPS, $1978 per person randomized, and $2505 per completer). The use of a single billboard displayed for 2 months during the levetiracetam ER RCT was the third most expensive modality used ($21,662), amounting to 12% of the total combined advertising budget. The billboard was placed at a strategic spot on the main artery into the downtown area but only led to 9 phone screens, 3 IPSs, and 2 completers ($10,831 per completer). Interestingly, 2 participants in the varenicline RCT reported learning about the study from seeing the billboard several months earlier during the prior levetiracetam ER RCT. One of those persons was a varenicline RCT completer.
Although there was no cost for the study or clinicaltrials.gov websites to investigators, $8300 was spent in placing e-mail list serve ads to area business professionals during the levetiracetam ER RCT and $1020 on Google AdWords during the varenicline RCT. No phone screens resulted from the list serve; all screens reporting the internet as the ad source came from the study website or Google AdWords.
DISCUSSION
Recruitment of eligible participants for pharmacologic intervention clinical trials of AUDs can be successfully obtained through a comprehensive and targeted advertising strategy. In this analysis, greater than half of the advertising dollars for 2 AUD pharmacotherapy trials were spent on 2 sources-TV and print ads. Not surprisingly, the majority of phone screens reported hearing about the study from these 2 sources. However, when looking at effectiveness of recruiting eligible participants, print ads produced the largest number of callers qualifying for IPSs, as well as the second largest number of persons randomized. Of those ad sources that cost money, print ads were also the most cost-effective strategy (approximately $2500 per completer in advertising dollars). In contrast, the professionally developed TV commercial resulted in a high number of interested callers (N = 346) but only 17% of those calls led to IPSs. In addition, the TV costs presented in this study are an underestimate, as the site investigators did not pay commercial production costs. The billboard was expensive and the least costeffective strategy for study recruitment, having the same number of completers (N = 2) as flyers.
Analysis of recruitment outcomes should not be exclusively concerned with costs and timelines. Recruitment strategies should also be judged by the final study population. Was it similar to the target population of heavy drinkers and are the statistical inferences gener-alizable? In this study, the majority of print ads were in the local free weekly newspapers, and these ads reached participants usually of a lower socioeconomic status, not in a committed relationship, and African American (Table 1)-demographic variables known to influence inclusion and outcomes from AUD pharmacologic clinical trials. [12] [13] [14] [15] In addition, most IPSs reporting TV as their ad source were white, perhaps influenced by the commercial. Although it was shot in black-and-white, the ad featured a middle-aged male with uncertain racial features. Nevertheless, the final site populations contained 42% non-white participants, a wide spread of socioeconomic status, and good distribution of marital statusesincreasing the demographic variability in the 2 larger multisite study populations. 9, 10 This analysis provides evidence for the use of diverse advertising sources when trying to recruit a study sample similar to the target population of AUD clinical trials. Use of 1 ad source would have limited the diversity of study participants and the generalizability of the study findings. These results do have limitations. First, persons may have needed to see advertisements in several locations or several times before finally calling for a screen as product advertising theory suggests. 16 These analyses only allowed a person to give 1 ad source and did not assess frequency of exposure to an ad before calling. Although a person may have seen the billboard and TV commercial, he or she may have listed the TV as the ad source because it was seen most proximal to the phone screen. Second, BPRU and other Baltimore area drug abuse research programs have historically used the local free weekly newspapers to advertise RCTs. People seeking treatment for AUDs and open to clinical trial participation may already know to look there. It may be that branching out into live media (TV and radio) will take several years to increase the number of qualified phone screens stemming from these strategies as awareness of these other advertising sources increases, as proposed by the theory of effective frequency in advertising. 17 There certainly was a trend for TV to be more effective at reaching qualified persons, as only 11% of TV phone screens led to IPSs in the first (levetiracetam ER) RCT, whereas this number increased to 19% in the second (varenicline) RCT. In addition, the impact of the internet for recruitment doubled in the varenicline RCT, with 35 phone screens listing internet as the ad source (compared with 16 in levetiracetam ER RCT). As access to the internet increases 18 -even among persons with alcohol and other drug-use disorders 19 -this may be an important tool reducing the cost of recruitment in future AUD RCTs. Third, this was an analysis of 1 site in 2 multisite clinical trials. These results may not be generalizable to other research locations even within these same clinical trials. Fourth, these analyses were performed across studies using 2 distinct pharmacologic agents. Although the inclusion/exclusion criteria were similar across studies, the varenicline RCT required a person never to have tried this medication in the past and also to have 2 very heavydrinking days during the screening period. These slight differences may have influenced study recruitment as there are documented racial differences in use of smoking cessation pharmacotherapies such as varenicline. 20 Finally, the exact same ad sources were not used in both studies. Knowledge from the levetiracetam ER RCT showed the poor efficacy for the billboard and radio for recruitment. More money was spent on TV and print ads during the varenicline RCT, and billboard and radio ads were not purchased (although they may have had enduring effects on recruitment for the second study).
In conclusion, recruitment of a diverse and generalizable study population in AUD clinical trials likely requires a multipronged advertising strategy. FIGURE 3 . Cost-effectiveness by ad source for phone screens, in-person screens, randomization, and study completion. The bus ad was not cost-effective in recruiting eligible study participants, with each completer costing in excess of $13,000 in advertising expenses alone. Print ads were the most cost-effective with each completer costing approximately $2500. IPS indicates in-person screen.
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Knowledge of local media markets is important and consultation with an ad agency may enhance recruitment goals to ensure adequate study power and a study population that closely resembles the target population. The most effective ad source for recruiting eligible participants in an alcohol RCT may be print ads, especially those in local free weekly papers. Use of higher cost billboards and radio ads may not be costeffective and should be used cautiously and only if other sources are unavailable or have proven ineffective.
